☆ 4.8 Article

Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Get Full Text
Add to Collection

Journal

CLINICAL AND TRANSLATIONAL MEDICINE
Volume 12, Issue 2, Pages -

Publisher

JOHN WILEY & SONS LTD
DOI: 10.1002/ctm2.732

Keywords

-

Categories

Oncology Medicine, Research & Experimental

Funding

  1. National Science Fund for Distinguished Young Scholars [82025022]
  2. National Natural Science Foundation of China [82002140, 82171752, 82101861]
  3. Guangdong Basic and Applied Basic Research Foundation [2021B1515020034, 2019A1515011197, 2021A1515011009, 2020A1515110656]
  4. Shenzhen Science and Technology Program [RCYX20200714114700046, JSGG20200207155251653, JSGG20200807171401008, KQTD20200909113758004, JCYJ20190809115617365]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.